125 related articles for article (PubMed ID: 6692099)
1. Urinary hydroxyproline and prognosis in human breast cancer.
Grant CS; Hoare SA; Millis RR; Hayward JL; Wang DY
Br J Surg; 1984 Feb; 71(2):105-8. PubMed ID: 6692099
[TBL] [Abstract][Full Text] [Related]
2. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
Gasser AB; Depierre D; Alberto P; Courvoisier B
Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
[TBL] [Abstract][Full Text] [Related]
3. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
[TBL] [Abstract][Full Text] [Related]
4. [Urinary hydroxyproline and cancer of the breast].
Bellido V; Carda P; Mascías E
Rev Esp Oncol; 1983; 30(1):7-16. PubMed ID: 6679910
[No Abstract] [Full Text] [Related]
5. Hydroxyproline excretion in the detection of occult bone metastases from breast cancer.
Rowse AD; Morrison MJ; Scott PH; Banks AJ; Roginski C
Oncology; 1982; 39(5):287-91. PubMed ID: 7099511
[TBL] [Abstract][Full Text] [Related]
6. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
Niell HB; Palmieri GM; Neely CL; McDonald MW
Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
[TBL] [Abstract][Full Text] [Related]
7. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
Cuschieri A
Br J Surg; 1973 Oct; 60(10):800-3. PubMed ID: 4748385
[No Abstract] [Full Text] [Related]
8. Total and nondialyzable hydroxyproline excretion in Stage D2 prostate cancer.
Hopkins SC; Palmieri GM; Niell HB; Moinuddin M; Soloway MS
Cancer; 1984 Jan; 53(1):117-21. PubMed ID: 6689994
[TBL] [Abstract][Full Text] [Related]
9. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Rinsho K; Aoyagi K
Tohoku J Exp Med; 1982 Aug; 137(4):461-2. PubMed ID: 7123546
[TBL] [Abstract][Full Text] [Related]
10. Early morning hydroxyproline excretion in patients with breast cancer.
Powles TJ; Rosset G; Leese CL; Bondy PK
Cancer; 1976 Dec; 38(6):2564-6. PubMed ID: 1000483
[TBL] [Abstract][Full Text] [Related]
11. [Hydroxyprolinuria and bone metastases of breast cancer].
Cruciani G; Bardella D; Fiorentini GM; Marangolo M; Tavolazzi L
Tumori; 1980 Apr; 66(2):205-13. PubMed ID: 7445102
[TBL] [Abstract][Full Text] [Related]
12. Urinary hydroxyproline excretion in carcinoma of the breast.
Cuschieri A; Felgate RA
Br J Exp Pathol; 1972 Jun; 53(3):237-41. PubMed ID: 5055709
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyproline and zinc excretion in patients with neoplastic breast disease.
Percudani M; Dell'Anna B; De Lorenzis GF; Ferraccioli GF; Vaona GL
Int Surg; 1981; 66(3):233-6. PubMed ID: 7319736
[TBL] [Abstract][Full Text] [Related]
14. [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
Gasser AB; Jeannet C; Depierre D; Courvoisier B
Schweiz Med Wochenschr; 1981 Feb; 111(8):246-51. PubMed ID: 7233140
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyproline excretion in patients with breast cancer and response to treatment.
Powles TJ; Leese CL; Bondy PK
Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
[TBL] [Abstract][Full Text] [Related]
16. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
Ditzel J; Jordal R; Riskoer N
Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
[No Abstract] [Full Text] [Related]
17. [Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
Kurokawa K; Imai K; Yamanaka H; Tomaru Y; Kitaura K
Hinyokika Kiyo; 1985 Dec; 31(12):2119-25. PubMed ID: 2421558
[TBL] [Abstract][Full Text] [Related]
18. Three-centre study on urinary hydroxyproline excretion in cancer of the breast.
Cuschieri A; Jarvie R; Taylor WH; Cant E; Furnival CM; Blumgart LH
Br J Cancer; 1978 Jun; 37(6):1002-5. PubMed ID: 678421
[TBL] [Abstract][Full Text] [Related]
19. Reference values and analytical performance of the hydroxyproline/creatinine ratio in early morning urine samples.
Posma FD; Groenewold H; Kluft O; Tuynman FH
J Clin Chem Clin Biochem; 1981 Apr; 19(4):209-12. PubMed ID: 7241058
[TBL] [Abstract][Full Text] [Related]
20. [Hydroxyprolinuria in relation to bone metastases in patients with breast cancer].
Rico Lenza H; Millán Núñez-Cortés J; Rodríguez Mora VI; Espinós Pérez D
Rev Esp Oncol; 1980; 27(1):61-6. PubMed ID: 7209108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
